CANNABIS investment company Greencare Capital has appointed Richard Tonthat as CEO just weeks after his work with British American Tobacco on its £125m equity stake in Canada’s Organigram.
Mr Tonthat, 37, qualified as a Chartered Accountant with PricewaterhouseCoopers and is an experienced corporate financier and investment adviser.
Prior to joining Greencare, he was an independent consultant advising on M&A, debt financing and equity investments. During this time, he worked with British American Tobacco plc on a number of transactions, including the recent C$221m equity investment into Organigram.
Previously he was a Director in the Corporate Finance team at Grant Thornton where he managed a portfolio of public company clients and had a proven track record of delivering multiple M&A, IPO, debt and private equity fundraising projects.
Nicholas Lee, Greencare’s Non-executive Chairman, said: “I am pleased to welcome Richard to the Greencare Board. His transaction experience and investment advisory background, combined with direct experience of the international cannabis market will be of great benefit to the company as we continue to build our investment portfolio.”
Greencare Capital plc is quoted on the Aquis Stock Exchange Growth Market. The Company was incorporated on October 1, 2019, and was admitted to the exchgange on December 30, 2019.
